Mr. Hezi Israel has been serving as Executive Vice President, ICL Corporate Development, M&A & Strategy since March 2012. Mr. Israel joined ICL in 2007 and served as Vice President Strategy and Business Development for ICL Industrial Products. Prior to joining ICL, Mr. Israel held a number of senior executive positions at Teva Pharmaceuticals Industries Ltd., in the areas of business development and global merger and acquisition activity.
Mr. Israel holds an M.B.A. from Tel Aviv University and a B.A. in Economics and Political Science from Tel Aviv University.